Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma (HCC)—the most common type ...
Patients enrolled had NET liver metastases of any grade or origin that were progressive, symptomatic, or represented a high ...
After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.
Dr. Anjana Pillai explains that staging liver cancer involves assessing tumor size, spread, and vessel involvement to guide ...
A new study has identified TRIM56, an E3 ubiquitin ligase, as a key activator of the proto-oncogene Src in hepatocellular ...
Liver cancer often goes undetected; awareness, early diagnosis, and prevention are crucial for improving outcomes and saving lives.
Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results